Hand Therapy Intervention Versus Traditional Occupational Therapy to Prevent Chemotherapy Induced Peripheral Neuropathy

Completed · Not applicable

Conditions studied: Adenocarcinoma of Pancreas

In brief

A pilot randomized feasibility trial with a blinded evaluator.

Key facts

Study ID

NCT05374876

Run by

HonorHealth Research Institute

People needed

49

Starts

2016-05-13

Expected to finish

2021-09-30

Last updated by the study team

2026-07-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with adenocarcinoma of the pancreas who will receive chemotherapy with albumin bound paclitaxel plus gemcitabine containing combination
• Patients who have no prior evidence of peripheral neuropathy of the hands
• Age 18 years or older
• Able to sit for minimum of 30 minutes for hand therapy sessions

You may not qualify if…

• Patients who have received at least one dose of chemotherapy with albumin bound paclitaxel plus gemcitabine during the past 6 months
• Patients taking duloxetine or gabapentin
• History of peripheral neuropathy of the hands due to chemotherapy, diabetes, or other causes
• Inability to sit for minimum of 30 minutes
• Documented cognitive problems limiting ability to participate in hand therapy

Where it is running

• HonorHealth Research Institute — Scottsdale, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.